Federal health regulators have approved an attention deficit disorder drug for a new use: A first-of-its kind treatment for binge-eating disorder.
Sun Pharmaceuticals will sell the rights to one generic drug as part of its purchase of competitor Ranbaxy Laboratories, U.S. antitrust regulators said Friday.
In his State of the Union address, President Obama announced a new precision medicine initiative to work on finding a cure for cancer and other diseases. Howard L. Kaufman, a leading immunotherapy expert ...
Earlier this month, the Centers for Disease Control and Prevention recommended the use of antiviral drugs to help treat influenza, in a year when the available vaccine is not a good match for the current ...
(HealthDay)—Nearly one in 10 American adults don't take their medications as prescribed because they can't afford to, health officials reported Thursday.
(HealthDay)—For certain people, the acne treatment Aczone may be linked to a rare blood disorder, a new case study contends.
Physicians explore why children with sickle cell disease are experiencing mixed results on hydroxyur
Electronic medication monitoring caps may help physicians put together the puzzle of why children taking a medicine that promises to curb sickle cell disease are showing mixed, confusing results.